[go: up one dir, main page]

DK1265621T3 - Anvendelse af CDP-cholin til profylaktisk behandling af cerebral iskæmi - Google Patents

Anvendelse af CDP-cholin til profylaktisk behandling af cerebral iskæmi

Info

Publication number
DK1265621T3
DK1265621T3 DK01921332T DK01921332T DK1265621T3 DK 1265621 T3 DK1265621 T3 DK 1265621T3 DK 01921332 T DK01921332 T DK 01921332T DK 01921332 T DK01921332 T DK 01921332T DK 1265621 T3 DK1265621 T3 DK 1265621T3
Authority
DK
Denmark
Prior art keywords
prophylactic treatment
cerebral ischemia
cdp choline
cdp
choline
Prior art date
Application number
DK01921332T
Other languages
Danish (da)
English (en)
Inventor
Rafael Foguet
Jose A Ortiz
Jorge Ramentol
Rafael Lozano
Manuel M Raga
Josep M Castello
Isidro J Ferrer
Julio J Secades
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Application granted granted Critical
Publication of DK1265621T3 publication Critical patent/DK1265621T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK01921332T 2000-03-14 2001-03-13 Anvendelse af CDP-cholin til profylaktisk behandling af cerebral iskæmi DK1265621T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200000610A ES2169986B1 (es) 2000-03-14 2000-03-14 Uso de cdp-colina para el tratamiento profilactico de la isquemia cerebral.

Publications (1)

Publication Number Publication Date
DK1265621T3 true DK1265621T3 (da) 2006-05-08

Family

ID=8492692

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01921332T DK1265621T3 (da) 2000-03-14 2001-03-13 Anvendelse af CDP-cholin til profylaktisk behandling af cerebral iskæmi

Country Status (21)

Country Link
US (2) US6930096B2 (fr)
EP (1) EP1265621B1 (fr)
JP (1) JP4920849B2 (fr)
KR (1) KR100883279B1 (fr)
AT (1) ATE314855T1 (fr)
AU (2) AU2001248346B2 (fr)
BR (1) BR0109155A (fr)
CA (1) CA2402668C (fr)
CZ (1) CZ300616B6 (fr)
DE (1) DE60116478T2 (fr)
DK (1) DK1265621T3 (fr)
ES (1) ES2169986B1 (fr)
IL (2) IL151165A0 (fr)
MX (1) MXPA02008917A (fr)
NO (1) NO330163B1 (fr)
NZ (1) NZ520824A (fr)
PL (1) PL199383B1 (fr)
PT (1) PT1265621E (fr)
RU (1) RU2255741C2 (fr)
WO (1) WO2001068064A2 (fr)
ZA (1) ZA200206348B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2169986B1 (es) * 2000-03-14 2003-06-16 Ferrer Int Uso de cdp-colina para el tratamiento profilactico de la isquemia cerebral.
CN1605336A (zh) * 2003-10-10 2005-04-13 中国医学科学院药物研究所 左旋丁基苯酞在制备预防和治疗脑梗塞的药物中的应用
RU2519228C1 (ru) * 2013-02-12 2014-06-10 Клиника государственного бюджетного образовательного учреждения высшего профессионального образования "Челябинская государственная медицинская академия" Министерства здравоохранения Российской Федерации Способ предупреждения ишемии головного мозга при реконструктивных операциях на прецеребральных сосудах
CA3138727A1 (fr) 2019-09-15 2021-03-18 Celagenex Research (India) Pvt. Ltd. Compositions bioactives synergiques pour traiter des troubles neurologiques

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2724825B2 (ja) 1987-06-15 1998-03-09 旭化成工業株式会社 シチジンジリン酸コリンの製造方法
RU2007170C1 (ru) * 1991-01-04 1994-02-15 Научно-исследовательский институт неврологии РАМН Средство для усиления антиагрегационного эффекта аспирина
JP3018823B2 (ja) * 1993-03-11 2000-03-13 キヤノン株式会社 非循環式シート材搬送装置
US5872108A (en) * 1995-03-06 1999-02-16 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
EP0813416B1 (fr) * 1995-03-06 2005-05-25 Interneuron Pharmaceuticals Incorporated Reduction de l'ampleur des infarctus par la citicoline
CN1122241A (zh) 1995-09-18 1996-05-15 牛俊江 脑脉通注射液
KR20000075788A (ko) * 1997-02-28 2000-12-26 데이비드 이. 프랭크하우저 유전자 치료에 의한 염증 세포의 자가-조절된 아포토시스
ES2169986B1 (es) * 2000-03-14 2003-06-16 Ferrer Int Uso de cdp-colina para el tratamiento profilactico de la isquemia cerebral.

Also Published As

Publication number Publication date
AU2001248346B2 (en) 2005-03-10
KR20030005225A (ko) 2003-01-17
RU2255741C2 (ru) 2005-07-10
US6930096B2 (en) 2005-08-16
WO2001068064A2 (fr) 2001-09-20
ATE314855T1 (de) 2006-02-15
BR0109155A (pt) 2003-04-22
US7635691B2 (en) 2009-12-22
PT1265621E (pt) 2006-05-31
CA2402668C (fr) 2008-01-08
PL199383B1 (pl) 2008-09-30
JP2003526657A (ja) 2003-09-09
AU4834601A (en) 2001-09-24
NO20024399D0 (no) 2002-09-13
MXPA02008917A (es) 2003-02-12
CA2402668A1 (fr) 2001-09-20
NO20024399L (no) 2002-09-13
DE60116478T2 (de) 2006-09-07
US20030050284A1 (en) 2003-03-13
IL151165A0 (en) 2003-04-10
KR100883279B1 (ko) 2009-02-11
CZ20023095A3 (cs) 2003-02-12
IL151165A (en) 2009-06-15
JP4920849B2 (ja) 2012-04-18
DE60116478D1 (de) 2006-03-30
NZ520824A (en) 2004-04-30
WO2001068064A3 (fr) 2002-01-17
EP1265621B1 (fr) 2006-01-04
CZ300616B6 (cs) 2009-07-01
ES2169986B1 (es) 2003-06-16
PL358249A1 (en) 2004-08-09
NO330163B1 (no) 2011-02-28
US20050222077A1 (en) 2005-10-06
EP1265621A2 (fr) 2002-12-18
ZA200206348B (en) 2003-08-20
RU2002127783A (ru) 2004-03-27
ES2169986A1 (es) 2002-07-16

Similar Documents

Publication Publication Date Title
FR16C0028I2 (fr) Vecteurs viraux et utilisation de ces derniers dans des methodes therapeutiques
MXPA02007915A (es) Mediador de lipido activado por aspirina.
PT1143967E (pt) Utilizacao de derivados anticonvulsivos para o tratamento de cefaleias em salvas
DE60213762D1 (de) Implementierung des SHA1 Algorithmusses
DK1196172T3 (da) (S,S)-reboxetin til behandling af kronisk smerte
DK2322187T3 (da) Anvendelse af uridin i kombination med cholin til behandling af hukommelses-lidelser
DE60106954D1 (de) Resorcin-derivate
DK1471871T3 (da) Behandling af neurologisk dysfunktion omfattende fructopyranosesulfamater og erytropoietin
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
CY1107531T1 (el) Χρηση αναστολεων πρωτεασομης για την αγωγη των διαταραχων ξηρου οφθαλμου
DK1228028T3 (da) Hydroxyicosatetraenoatsalte, præparater og fremgangsmåder til anvendelse til behandling af öjentörhedslidelser
MXPA04006572A (es) Terapia de combinacion antivirica.
BRPI0515776A (pt) auxiliares de retenção e drenagem
DK1265621T3 (da) Anvendelse af CDP-cholin til profylaktisk behandling af cerebral iskæmi
PT1268482E (pt) Piranoindois para o tratamento de glaucoma
NO20005548D0 (no) Mykobakterieinhibitorer
Michel Fundamental concepts for the study of crystal symmetry
EP1326640A4 (fr) Therapie antiretrovirale a base d'inhibiteurs de la transcriptase inverse
DK1248638T3 (da) Anvendelse af enoxaparin til behandling af cerebral iskæmi
ES1049954Y (es) Zocalo para alojamiento de hembrillas y microreles.
NO20002629D0 (no) Strekkapparat for kropp/rygg
ES1046202Y (es) Soporte para alineacion y fijacion de tabicas.
ES1045848Y (es) Abrazadera para la fijacion de verjas.
ES1047876Y (es) Consola de oprecion para aparatos medicos.
ES1053732Y (es) Soporte para sustentacion y sujecion de tejidos y organos.